Inhibition of death receptor signals by cellular FLIP M Irmler, M Thome, M Hahne, P Schneider, K Hofmann, V Steiner, ... Nature 388 (6638), 190-195, 1997 | 3471 | 1997 |
Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule N Holler, R Zaru, O Micheau, M Thome, A Attinger, S Valitutti, JL Bodmer, ... Nature immunology 1 (6), 489-495, 2000 | 2308 | 2000 |
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations F Mackay, SA Woodcock, P Lawton, C Ambrose, M Baetscher, ... The Journal of experimental medicine 190 (11), 1697-1710, 1999 | 1851 | 1999 |
Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape M Hahne, D Rimoldi, M Schröter, P Romero, M Schreier, LE French, ... Science 274 (5291), 1363-1366, 1996 | 1772 | 1996 |
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth P Schneider, F MacKay, V Steiner, K Hofmann, JL Bodmer, N Holler, ... The Journal of experimental medicine 189 (11), 1747-1756, 1999 | 1732 | 1999 |
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors M Thome, P Schneider, K Hofmann, H Fickenscher, E Meinl, F Neipel, ... Nature 386 (6624), 517-521, 1997 | 1712 | 1997 |
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin I Viard, P Wehrli, R Bullani, P Schneider, N Holler, D Salomon, T Hunziker, ... Science 282 (5388), 490-493, 1998 | 1447 | 1998 |
The molecular architecture of the TNF superfamily JL Bodmer, P Schneider, J Tschopp Trends in biochemical sciences 27 (1), 19-26, 2002 | 1310 | 2002 |
IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis JE Vince, WWL Wong, N Khan, R Feltham, D Chau, AU Ahmed, ... Cell 131 (4), 682-693, 2007 | 1288 | 2007 |
BAFF AND APRIL: a tutorial on B cell survival F Mackay, P Schneider, P Rennert, J Browning Annual review of immunology 21 (1), 231-264, 2003 | 1285 | 2003 |
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF JS Thompson, SA Bixler, F Qian, K Vora, ML Scott, TG Cachero, ... Science 293 (5537), 2108-2111, 2001 | 1238 | 2001 |
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome J Groom, SL Kalled, AH Cutler, C Olson, SA Woodcock, P Schneider, ... The Journal of clinical investigation 109 (1), 59-68, 2002 | 1167 | 2002 |
Cracking the BAFF code F Mackay, P Schneider Nature reviews immunology 9 (7), 491-502, 2009 | 1122 | 2009 |
Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity P Schneider, N Holler, JL Bodmer, M Hahne, K Frei, A Fontana, ... The Journal of experimental medicine 187 (8), 1205-1213, 1998 | 1023 | 1998 |
TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB P Schneider, M Thome, K Burns, JL Bodmer, K Hofmann, T Kataoka, ... Immunity 7 (6), 831-836, 1997 | 942 | 1997 |
BAFF mediates survival of peripheral immature B lymphocytes M Batten, J Groom, TG Cachero, F Qian, P Schneider, J Tschopp, ... The Journal of experimental medicine 192 (10), 1453-1466, 2000 | 923 | 2000 |
TRAIL receptor-2 signals apoptosis through FADD and caspase-8 JL Bodmer, N Holler, S Reynard, P Vinciguerra, P Schneider, P Juo, ... Nature cell biology 2 (4), 241-243, 2000 | 864 | 2000 |
Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans U Salzer, HM Chapel, ADB Webster, Q Pan-Hammarström, ... Nature genetics 37 (8), 820-828, 2005 | 809 | 2005 |
MyD88, an adapter protein involved in interleukin-1 signaling K Burns, F Martinon, C Esslinger, H Pahl, P Schneider, JL Bodmer, ... Journal of biological chemistry 273 (20), 12203-12209, 1998 | 807 | 1998 |
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth M Hahne, T Kataoka, M Schröter, K Hofmann, M Irmler, JL Bodmer, ... The Journal of experimental medicine 188 (6), 1185-1190, 1998 | 778 | 1998 |